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Abstract
Background: The clinical outcomes following intrasynovial flexor tendon repair are highly variable. Excessive
inflammation is a principal factor underlying the formation of adhesions at the repair surface and affecting matrix
regeneration at the repair center that limit tendon excursion and impair tendon healing. A previous in-vitro
study revealed that adipose-derived mesenchymal stromal cells (ASCs) modulate tendon fibroblast response to
macrophage-induced inflammation. The goal of the current study was therefore to explore the effectiveness of
autologous ASCs on the inflammatory stage of intrasynovial tendon healing in vivo using a clinically relevant
animal model.
Methods: Zone II flexor tendon transections and suture repairs were performed in a canine model. Autologous ASC
sheets were delivered to the surface of repaired tendons. Seven days after repair, the effects of ASCs on tendon
healing, with a focus on the inflammatory response, were evaluated using gene expression assays, immunostaining,
and histological assessments.
Results: ASCs delivered via the cell sheet infiltrated the host tendon, including the repair surface and the space
between the tendon ends, as viewed histologically by tracking GFP-expressing ASCs. Gene expression results
demonstrated that ASCs promoted a regenerative/anti-inflammatory M2 macrophage phenotype and regulated
tendon matrix remodeling. Specifically, there were significant increases in M2-stimulator (IL-4), marker (CD163 and
MRC1), and effector (VEGF) gene expression in ASC-sheet treated tendons compared with nontreated tendons.
When examining changes in extracellular matrix expression, tendon injury caused a significant increase in scar-
associated COL3A1 expression and reductions in COL2A1 and ACAN expression. The ASC treatment effectively
counteracted these changes, returning the expression levels of these genes closer to normal. Immunostaining
further confirmed that ASC treatment increased CD163+ M2 cells in the repaired tendons and suppressed cell
apoptosis at the repair site.
Conclusions: This study provides a novel approach for delivering ASCs with outcomes indicating potential for
substantial modulation of the inflammatory environment and enhancement of tendon healing after flexor tendon
repair.
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tendon, Flexor tendon, Inflammation, Macrophage
* Correspondence: gelberman@wudosis.wustl.edu; sat2@columbia.edu
1Department of Orthopaedic Surgery, Washington University, 660 South
Euclid, Campus, Box 8233, St. Louis, MO 63110, USA
5Department of Orthopedic Surgery, Columbia University, Black Building
1408, 650 W 168 ST, New York, NY 10032, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shen et al. Stem Cell Research & Therapy  (2016) 7:144 
DOI 10.1186/s13287-016-0406-0
Background
Laboratory and clinical research has led to improve-
ments in the outcomes of flexor tendon repair through
enhanced suture methods and refined rehabilitation pro-
tocols [1, 2]. However, poor healing at the repair site can
lead to gapping, adhesion formation, and rupture, se-
verely impeding return of digital function in a significant
number of patients [3, 4]. Tendon healing is a complex
process consisting of three sequential overlapping stages:
inflammation, proliferation, and remodeling [5–7]. Al-
though most reported complications have occurred
within the first 3 postoperative weeks [2, 3], recent bio-
logic approaches have focused on the later proliferation
and remodeling stages and have shown limited positive
effects [8, 9]. Modulation of the early inflammatory re-
sponse that initiates the repair process may therefore be
necessary for a satisfactory recovery of tendon function.
The inflammatory cascade following tendon injury and
repair is dynamic and complex. Within the first 2–3
days, gene expression levels of proinflammatory cyto-
kines increase by many thousand-fold at the wound site
[6]. Such increases are accompanied by the infiltration
of large numbers of inflammatory cells, including mono-
cytes and neutrophils [6]. The initial postrepair cellular
response, which often leads to adhesion formation,
matrix degradation, and cell death [6, 7, 10], is largely
detrimental to tendon healing. Broad attempts to sup-
press inflammation after tendon repair, however, may
prevent the recruitment of regenerative fibroblasts (FBs)
and impair the tendon healing process. Careful modula-
tion of the inflammatory cascade is therefore necessary
to improve tendon healing, specifically by suppressing
negative features such as tendon cell death and matrix
degradation and by enhancing positive features associ-
ated with tendon cell proliferation and matrix synthesis.
The primary inflammatory cells that infiltrate the re-
pair site during flexor tendon healing are macrophages,
which are derived from monocytes [6]. Depending on
their local environment, macrophages acquire distinct
phenotypes, which may be classified into two major cat-
egories: a proinflammatory type 1 (M1) and an anti-
inflammatory type 2 (M2) phenotype [11]. Although M1
macrophages are necessary for the clearance of damaged
tissue and the initiation of healing response, they also
produce the proinflammatory cytokines IL-1, TNF-α,
and IL-6 as well as cytotoxic reactive oxygen and nitro-
gen intermediates. Collectively, these factors induce in-
flammation, scar formation, cell death, and matrix
degradation, thus impeding tendon healing. In contrast,
M2 macrophages produce anti-inflammatory IL-1 recep-
tor antagonist (IL-1RA) and IL-10, growth factors, and
extracellular matrix, thus mitigating inflammation and
scarring and facilitating matrix remodeling and wound
healing [11]. The M1 macrophages are reported to
dominate the early inflammatory stage of tendon heal-
ing, while the M2 macrophages are mainly detected in
the latter remodeling stage [12, 13]. Promotion of the
M2 phenotype during the earliest stages of tendon heal-
ing may therefore limit harmful inflammation, protect-
ing both tendon cells and matrix, and facilitating tissue
regeneration.
The M2 phenotype may be induced through the
immunoregulatory function of adipose-derived mesen-
chymal stromal cells (ASCs). In addition to their easy ac-
cessibility and tenogenic potential [14], we recently
reported that ASCs protect tendon fibroblasts (TFs)
from the negative effects of M1 macrophages by indu-
cing an M1 to M2 phenotypic switch in vitro [15].
Others have shown, in a cutaneous wound healing
model, that mesenchymal stromal cells (MSCs) derived
from gingiva consistently induce the M2 phenotype and
improve healing [16]. Nevertheless, whether undifferen-
tiated ASCs can regulate the macrophage phenotype and
ultimately improve flexor tendon healing in vivo remains
unclear. The goal of this study was therefore to evaluate
the impact of autologous ASCs on the early inflamma-
tory stage of flexor tendon healing. The hypothesis of
this study was that autologous ASCs, delivered to the re-
pair surface, would infiltrate the repair site, improve
matrix remodeling, and facilitate tendon healing via pro-
moting macrophages toward the M2 phenotype and
therefore away from the M1 phenotype.
Methods
Autologous ASC sheet preparation and in-vitro
characterization
Subcutaneous fat was obtained 2 weeks prior to tendon
repair for ASC isolation and subsequent cell sheet prep-
aration. ASC isolation and culture was performed as de-
scribed previously [14]. To prepare ASC sheets, 1 ml of
collagen solution (pH 7.2), containing 2 mg/ml type I
collagen from rat tail tendon (Corning Life Sciences,
Bedford, MA, USA), was added to a ring-shaped silicone
insert (Ø 19 mm) placed in a well of a six-well plate and
incubated at 37 °C for 1 h to gel. The gelled collagen
was equilibrated overnight in α -MEM (Mediatech, Inc.,
Manassas, VA, USA) containing 10 % fetal bovine serum
(Hyclone Laboratories, Logan, UT, USA) and 100 U/ml
penicillin–steptomycin (Life Technologies, Gaithersburg,
MD, USA). Passage 3 ASCs were then plated on top of
the collagen layer at a density of 10,000 cells/cm2. The
resulting cell sheet was cultured for 3–4 days in vitro
with medium change every other day (Fig. 1a, b). To
track ASCs in vitro and in vivo, some cell sheets were
prepared with ASCs pretransduced with green fluores-
cent protein (GFP)-expressing lentivirus.
The viability of ASCs in the cell sheet was examined
after 5 days in culture by staining live cell sheets with
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propidium iodide (PI; Life Technologies) according to
the manufacturer’s instructions. Phase-contrast and
fluorescent images were taken at four different areas of
each stained cell sheet (N = 3 cell isolations). The num-
bers of total and PI-positive cells at each of the four
areas were quantified and averaged. Cell viability for
each sample was calculated as the ratio of total cell
count minus PI-positive cell count, divided by total cell
count, and presented as a percentage. To estimate the
population doubling time of the ASCs, cell sheets cul-
tured for 7 days were fixed with 4 % paraformaldehyde
(PFA) in phosphate-buffered saline (PBS) for 15 min and
then stained with bisBenzimide H 33258 (Sigma-Aldrich,
St. Louis, MO, USA). The total number of cells within
the cell sheets was determined by counting the stained
nuclei. The population doubling time of each sample
(N = 3 cell isolations) was subsequently calculated ac-
cording to initial cell counts and culture duration.
To determine the cell distribution within ASC sheets,
GFP-expressing ASC sheets were fixed in 4 % PFA for
15 min. After three washes with PBS, the ASC sheets
were mounted on a coverslip. Z-stack images were ob-
tained under a confocal microscope (Zeiss LSM 5 PAS-
CAL) equipped with a 40×/1.4 oil immersion lens. 3-D
images were generated with Zeiss LSM Image Browser
4.2.0.121.
Development of surgical methods for ASC sheet
implantation
A cell delivery system was developed to overcome a num-
ber of challenges associated with application of ASCs to
repaired flexor tendons. Intrasynovial tendons have: small
cross-sectional areas (limiting the volume of material that
can be delivered); a high density of extracellular matrix
(limiting the diffusion of factors and/or infiltration of
cells); and a special need for local delivery (promoting
healing at the repair site without concurrent promotion of
adhesions between the tendon surface and its sheath). Be-
cause prior efforts to apply ASCs to flexor tendon using
polymer-based scaffolds inserted into slits within the ten-
don stumps had negative effects on tendon healing [8], a
new cell sheet delivery system was developed.
The ASC sheet did not readily adhere to the flexor
tendon surface, so a series of cadaver studies were per-
formed to develop methods for implantation of the ASC
sheet during surgical repair. Hyaluronan-based materials
can suppress adhesions at the flexor tendon surface and
improve tendon gliding [17, 18]. Therefore, a hydrogel
consisting of thiol-modified hyaluronan (HA; Biotime,
Inc, Alemeda, CA, USA [19]) was used to immobilize
the ASC sheet on the tendon surface. The hydrogel was
crosslinked in situ with polyethylene glycol diacrylate.
PBS was chosen over Ringer’s solution as the gelling
Fig. 1 Generation of ASC sheet. a Schematic illustration of ASC sheet preparation. b Representative image of an ASC sheet in a well of a six-well
plate. c 3-D projection of an ASC sheet, revealing the GFP-expressing ASCs (green) in the collagen matrix. Cell nuclei were counterstained with
bisBenzimide H 33258 (blue). Bar = 20 μm. d Depth-coded image of (c). Blue and red color scale indicates the closest and furthest, respectively,
from the surface of the ASC sheet. ASC adipose-derived mesenchymal stromal cell
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buffer to obtain consistent gelation time. With the buf-
fer, approximately 5 min of gelation time resulted in an
appropriate viscosity for application of the hydrogel to
the tendon surface, and an additional 5 min was neces-
sary to ensure complete gelation and proper adhesion of
the hydrogel to the tendon. Three cadaver flexor tendon
repairs were performed with application of ASC sheets
onto the repair site followed by a layer of HA. After gel-
ation, both synovial sheath and skin were closed and
passive motion was applied to the paw to mimic the re-
habilitation protocol performed in live animals. After
24 hours, the repaired tendons were exposed, visually
examined, and dissected for histological assessment. In
all cases, ASC sheets remained over the repair site cov-
ered in the hydrogel. Moreover, the implanted cells mi-
grated from the cell sheet wrapping around the tendon
surface to the gap between the ends of the severed ten-
don stumps and within the tendon substance.
In-vivo animal model
A clinically relevant canine animal model of intrasyno-
vial flexor tendon injury and repair was used in 12
female adult mongrel dogs (20–30 kg) [20]. Mature ani-
mals were chosen to obtain adult ASCs. Tendon transec-
tion and repair were performed as described previously
in Zone II of the second and the fifth flexor digitorum
profundus (FDP) tendons of the right front paw of each
animal [6, 9]. After two washes with sterile saline, an
autologous ASC sheet was wrapped around a repaired
tendon with the cell side facing the tendon (Fig. 2a) and
secured in place using HA (Fig. 2b). Five animals re-
ceived ASC sheets in both repaired digits (+ ASC
sheet group). One digit was used for histological study
and the other digit was used for gene expression analysis.
The remaining seven animals received HA alone in one of
the repaired digits (+ HA group) and no treatment in the
other repaired digits to serve as HA and repair only con-
trol groups, respectively. Among the seven animals, two
were used for histology, two were used for gene expres-
sion analysis, and three were used for both histology and
the gene expression analysis. The latter was achieved by
dividing each repaired tendon longitudinally into two
parts along the sagittal plane. The corresponding unin-
jured contralateral digits of all animals served as normal
healthy controls. All repaired digits received controlled
passive mobilization starting 24 hours after surgery as de-
scribed previously [6, 9]. Animals were euthanized 7 days
after repair.
RNA isolation and real-time quantitative RT-PCR
Tendon fragments flanking the repair site (~1 cm) were
dissected, diced into small pieces, and then pulverized
with a Mikro-Dismembrator (Sartorius). Total RNA was
subsequently isolated with Trizol Reagent (Life Tech-
nologies, Carlsbad, CA, USA) and RNeasy Mini Spin
Columns (Qiagen Sciences, Germantown, MD, USA), as
described previously [14]. The resulting total RNA
(500 ng) was reverse-transcribed into first-strand cDNA
using a SuperScript VILO cDNA Synthesis Kit (Life
Technologies), according to the manufacturer’s instruc-
tions. An initial survey for changes in gene expression
was performed with TaqMan real-time PCR by Washing-
ton University Genome Technology Access Center using
the Fluidigm Biomark™ HD system. All TaqMan primers
and probes used in this study were purchased from Ap-
plied Biosystems (Table 1). The relative abundances of
Fig. 2 Application of an ASC sheet in tendon repair. a, b Representative photographs showing the process of applying a an ASC sheet and b HA
to a sutured FDP tendon. c Representative photograph showing a FDP tendon 7 days after ASC sheet repair. d Representative fluorescent image
of a whole-mount FDP tendon repaired with a GFP-expressing ASC sheet. e, f Representative fluorescent image of a longitudinal section of a FDP
tendon repaired with a GFP-expressing ASC sheet. f Enlarged image of the boxed region in e. Arrows, site of tendon repair; open arrowheads,
GFP-expressing cells in the tendon substance
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target genes in repaired digits were analyzed with the
comparative Ct (2–ΔΔCt) method using GAPDH and
PPIB as endogenous reference genes and compared with
those of corresponding normal digits. A follow-up gene
expression study was performed to examine macrophage
phenotype using SYBR green-based real-time PCR. The
relative abundance of target genes in repaired digits was
analyzed with the 2–ΔΔCt method using GAPDH as the
endogenous reference gene and compared with those of
corresponding normal digits. A maximum Ct value of 40
was assigned to nondetectable samples. The SYBR green
PCR primers of all target genes were purchased from
Qiagen (Table 2), except for SCX whose primers have
been described previously [14].
Histology
FDP tendons were pinned with slight tension on corks
and fixed in 4 % PFA in PBS overnight. After three
washes with PBS, the fixed tissues were examined and
imaged under a fluorescence microscope to determine
the location of ASC sheets relative to the repair site. Tis-
sues were then either equilibrated with 30 % sucrose in
PBS at 4 °C overnight and embedded in Tissue-Tek
O.C.T. compound or dehydrated and embedded in
paraffin. Serial coronal sections were then prepared. To
evaluate the distribution of ASCs delivered via cell sheet
in the repaired tendons, sections (8 μm thick) were coun-
terstained with bisBenzimide H 33258 every 100 μm in
depth. Additional sections were stained with hematoxylin
and eosin (H&E). Histological assessment was performed
blindly on H&E-stained sections (one middle section per
tissue) by an independent, board-certified pathologist
(NH) using a light microscope equipped with a 20× ob-
jective. Each section was divided into three regions relative
to the repair site: proximal, center, and distal. Each region
was graded for overall cellularity, FBs, polymorphonuclear
cells (PMNs), mononuclear cells (MNs), and vascularity,
as detailed in Table 3.
Immunofluorescence staining
Immunofluorescence staining was performed on frozen
sections of tendon tissues. After a brief wash with PBS,
the sections were permeabilized in 0.5 % Triton X-100
(Sigma-Aldrich) in PBS for 15 min and blocked with 5 %
normal donkey serum in PBS containing 0.1 % Triton X-
100 for 30 min. The sections were then incubated with
either goat anti-CD163 (sc-1879, 1:50 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or rabbit anti-
cleaved caspase-3 (#9661, 1:400 dilution; Cell Signaling
Technology, Beverly, MA, USA) antibodies at 4 °C
overnight, followed by Dylight 549-conjugated donkey
anti-goat or Cy3-conjugated donkey anti-rabbit (1:400 di-
lution; Jackson ImmunoResearch, West Grove, PA, USA)
Table 1 TaqMan primer and probes used in the study
Gene
symbol




ACAN Cf02674826_m1 NM_001113455.1 125
CD163 Cf02627309_m1 NM_001048020.1 78
COL1A1 Cf02623126_m1 NM_001003090.1 87
COL2A1 Cf02622836_m1 NM_001006951.1 72
COL3A1 Cf02631370_m1 XM_535997.2 78
COL5A1 Cf02645008_m1 XM_537804.2 77
DCN Cf02628561_m1 NM_001003228.1 78
GAPDH Cf04419463_gH NM_001003142.1 54
IL1B Cf02671953_g1 NM_001037971.1 78
IL6 Cf02624152_g1 NM_001003301.1 80
MMP1 Cf02651000_g1 XM_546546.2 63
MMP3 Cf02625960_m1 NM_001002967.1 79
MMP13 Cf02623587_m1 XM_536598.2 78
PPIB Cf02629556_m1 M_535510.2 78
PTGS1 Cf02624717_m1 NM_001003023.1 75
PTGS2 Cf02625600_g1 NM_001003354.1 90
SOX9 Cf02625134_g1 NM_001002978.1 103
TGFB1 Cf02623324_m1 NM_001003309.1 83
TGFB3 Cf02625275_m1 XM_849026.1 118
TNF Cf02628236_m1 NM_001003244.4 75
TNMD Cf02665570_m1 XM_538101.2 106
VEGFA Cf02623448_m1 NM_001003175.2 69









GAPDH QT00896756 NM_001003142 83
IFN-G QT00897036 NM_001003174 136
IL10 QT01119804 NM_001003077 119
IL13 QT00898821 NM_001003384 137
IL1RN QT00896189 NM_001003096 89
IL4 QT00896931 NM_001003159 93
MRC1 QT01361703 XM_544242 90
NOS2 QT01118831 NM_001003186 75
Table 3 Scoring system for histological assessment of FDP
tendons
Score Cellularity/PMN/MN FB Vascularity
1 <50 cells per HPF <5 % <5 vessels per HPF
2 51–100 cells per HPF 6–50 % 6–10 vessels per HPF
3 101–150 cells per HPF >50 % >10 per HPF
4 >150 cells per HPF
FDP flexor digitorum profundus, PMN polymorphonuclear cell, MN mononuclear
cell and macrophage, FB fibroblast, HPF high-power field under
a 20 × objective
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antibodies for 1 h. After thorough washes, the stained sec-
tions were mounted in a mounting medium containing
DAPI nuclear staining reagent (Vector Laboratories,
Burlingame, CA, USA). Immunostainings without primary
antibodies were included in parallel with each experiment
to exclude nonspecific signals. The assessment of immu-
nostainings was performed blindly on two sections per
sample.
Statistics
All data are shown as mean ± standard deviation. A one-
way analysis of variance (ANOVA) followed by Student–
Newman–Keuls’s post-hoc testing (when appropriate)
was performed to compare gene expression among the
three repair groups. Two-tailed Student’s t tests and
Mann–Whitney rank sum tests were used to compare
the repair and normal groups for normally and nonnor-
mally distributed data, respectively. All statistic analyses
were performed using SigmaStat 3.5 (Systat Software,
Inc., Chicago, IL, USA). The significance level was set at
P < 0.05.
Results
In-vitro characterization of the ASC sheet
The ASC sheet, generated by culturing ASCs on the top
of a layer of type I collagen, was approximately 500 μm
thick (Fig. 1a, b). Within the sheet, ASCs formed
three to five cell layers within 100 μm from the sur-
face (Fig. 1c, d). The survival rate of ASCs in the sheet
was 95.6 ± 0.3 % (N = 3) after 5 days in culture. The calcu-
lated population doubling time of ASCs in the sheet after
7 days in culture was 1.9 ± 0.4 days (N = 3), comparable
with that of ASCs in conventional culture [14]. Taken to-
gether, the results demonstrated the successful generation
of a viable ASC sheet.
Implantation of ASC sheet in vivo
ASC sheets were wrapped around sutured FDP tendons
at the repair site with the cell side facing the tendons
(Fig. 2a). Gelling HA was subsequently applied to secure
ASC sheets in place (Fig. 2b). After the HA gelled, the
synovial sheath and skin were closed with sutures. All
ASC sheet-treated tendons were evaluated 7 days after
repair. There were no gaps greater than 3 mm and there
were no apparent adhesions in any of the repairs at dis-
section (Fig. 2c).
ASCs were pretransduced with lentivirus to express
GFP. Based on the pattern of GFP expression in whole-
mount tendons, the implanted ASC sheets were clearly
retained at the repair site and remained in contact with
the host tendons (Fig. 2d; N = 5). Images from longitu-
dinal sections further revealed that the GFP-expressing
cells filled the gap spaces between the two ends of trans-
ected and repaired tendon stumps (Fig. 2e, f; N = 5), with
some cells migrating to the tendon substance (open ar-
rows in Fig. 2e; N = 5). These results demonstrated that
viable cells were successfully delivered to the tendon re-
pair site using ASC sheets held in place by HA.
Impact of ASC sheet treatment on tendon histology
FDP tendon histology was evaluated on H&E-stained
sections from the three repair groups (N = 4–5 per
group). For semiquantitative analysis, each tendon sec-
tion was divided into three regions relative to the site of
tendon incision (proximal, center, and distal) and evalu-
ated for overall cellularity, vascularity, and relative abun-
dances of PMNs, MNs, and FBs at the tendon surface of
each region using a scoring system described in the
Methods section (Table 3). Among the three regions
evaluated, only the proximal regions (adjacent to the
blood supply provided by vincula) contained obvious
vasculature, and these regions were also enriched in FBs
(Table 4). As anticipated, the application of autologous
ASCs to the tendon surface increased the number of FBs
at the distal surface. The treatment, however, did not in-
crease the number of FBs at the surface of the repair
center and in the regions proximal to the repair (Table 4).
ASCs implanted at these regions likely migrated away
from the surface to the deep tendon substance, as ob-
served in GFP-expressing tendon sections (Fig. 2e, f ).
Effect of ASC sheet treatment on macrophage
polarization
In light of the potential of ASCs to modulate macro-
phage phenotype [15], we examined the expression levels
of the M2 stimulator genes IL-4, IL-13, and IL-10 and
the M2 marker genes MRC1 and CD163 in FDP tendons
from the normal, repair only, + HA, and + ASC sheet
groups (N = 5 per group). The results showed that ASC
Table 4 Average histological scores of flexor tendons at proximal, center, and distal regions of repair site
Distal Center Proximal
Group Cellularity PMN MN FB Vascularity Cellularity PMN MN FB Vascularity Cellularity PMN MN FB Vascularity
Repair only 1 0 1 0.5 0 1 1 1 1.5 0 2 1 1 2 2
+HA 1 0 1 0 0 1 1 1 0.5 0 2 1 1 2 2
+ASC sheet 1 1 1 1 0 1 1 1 0.5 0 2 1 1 2 2
PMN polymorphonuclear cell, MN mononuclear cell and macrophage, FB fibroblast cell, HA hyaluronan, ASC adipose-derived mesenchymal stromal cell
Shen et al. Stem Cell Research & Therapy  (2016) 7:144 Page 6 of 13
treatment significantly increased IL-4 and IL-13 expres-
sion by 258-fold and 4-fold, respectively (Fig. 3a, b). In
contrast, no significant changes in these genes were de-
tected in the tendons from the + HA and repair only
groups (Fig. 3a, b). IL-10 expression was universally in-
creased in tendons from all repair groups, without ap-
parent group differences (Fig. 3c). The expression of M2
marker genes MRC1 and CD163 was higher in ASC-
treated tendons than in tendons from the other repair
groups (Fig. 3d, e). Although the expression levels of M1
stimulator genes IFNG, IL-1B, TNFA, and IL-6 and
marker NOS2 were increased after FDP tendon repair,
there were no significant differences in expression levels
among the three repair groups, except for NOS2
(Fig. 3f–j). There was a trend for reduced expression of
this M1 marker gene after either HA or ASC treatment.
Consistent with the gene expression results, immuno-
staining demonstrated CD163+ cells at the tendon sur-
face (braced regions in Fig. 4a–d) and at the repair site
(dotted lines in Fig. 4c, d). ASC sheet-treated repairs had
increased numbers of CD163+ cells in both regions com-
pared with + HA repairs (Fig. 4). Together, these results
support a role of ASC sheet in promotion of the M2
phenotype during the early stages of tendon healing.
Effect of ASC sheet treatment on downstream factors
related to macrophage activation
M2 macrophages have been reported to modulate in-
flammation, tissue repair, and angiogenesis in a variety
of tissues [11]. Therefore, we examined the expression of
M2-related genes in FDP tendons from the normal, re-
pair only, + HA, and + ASC sheet groups (N = 5 per
group). Although PTGS2 (encoding cyclooxygenase 2
(COX2)) expression was significantly increased in all re-
pair groups (Fig. 5b), PTGS1 (encoding COX1) was no-
ticeably reduced after suture repair (Fig. 5a), and ASC
sheet treatment further reduced the PTGS1 level by over
80 % (Fig. 5a). IL1RN (encoding IL-1RA) was increased
in all repair groups (Fig. 5c). While TGFB1 expression
changed minimally in tendons from any of the repair
groups (Fig. 5d), TGFB3 was moderately increased after
suture repair (Fig. 5e). ASC sheets prevented much of
the postoperative increase of TGFB3 in the repaired ten-
dons. ASC sheet treatment increased expression of the
angiogenic factor VEGFA in FDP tendons, which was
significantly reduced after suture repair compared with
normal (Fig. 5f ). Thus, consistent with M2 macrophage
activities, ASC sheets positively modulated tendon re-
sponses following intrasynovial tendon repair.
Fig. 3 Change in expression of genes associated with macrophage polarization in FDP tendons 7 days post operatively. M2 stimulator genes:
a IL-4, b IL-13, and c IL-10. M2 marker genes: d MRC1 and e CD163. M1 stimulator genes: f IFNG, g IL-1B, h TNFA, and i IL-6. M1 marker: j NOS2.
*P <0.05 between indicated groups. #P < 0.05 and aP < 0.095, respectively, compared with normal tendons. HA hyaluronan, ASC adipose-derived
mesenchymal stromal cell
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Fig. 4 Impact of ASC sheets on M2 macrophage phenotype in FDP tendons 7 days after repair. Representative immunofluorescence images
of FDP tendon sections from the + HA (A, A′, and C) or + ASC sheet (B, B′, and D) groups at the tendon surface (A, A′, B, and B′) or repair site
(C and D). All sections were stained with M2 macrophage marker CD163 (red) and DAPI nuclear stain (blue). E Location index indicating the
location of A–D relative to the tendon repair in a tendon section stained with H&E. A–D Braces indicate epitenon regions. C, D Dotted lines
indicate site of tendon transection. Bar = 100 μm for A and B, bar = 50 for A′ and B′, and bar = 100 μm for C and D
Fig. 5 Change in expression of genes associated with downstream effects following macrophage activation in FDP tendons 7 days post
operatively. a PTGS1, b PTGS2, c IL1RN, d TGFB1, e TGFB3, f VEGFA. *P < 0.05 between indicated groups. aP = 0.062 and #P < 0.05, respectively,
compared with normal tendons. HA hyaluronan, ASC adipose-derived mesenchymal stromal cell
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Effect of ASC sheet treatment on tendon matrix
formation and remodeling
Because MSCs and M2 macrophages are known to pro-
mote tissue growth and matrix remodeling [21, 22], we
examined the expression of genes related to TF pheno-
type and tendon matrix formation and remodeling.
Compared with normal tendons, tendon injury and re-
pair led to significant changes in all genes investigated
(except TNMD) in each of the three repair groups
(Fig. 6). Although the tenogenic transcription factor SCX
(Fig. 6a) and the tendon matrix gene DCN (Fig. 6f ) were
both significantly reduced in the repaired tendons com-
pared with normal, the expression of tendon matrix
genes COL1A1, COL3A1, and COL5A1 were dramatic-
ally increased (Fig. 6c–e). When examining MMP gene
expression, MMP1 (Fig. 6g) and MMP13 (Fig. 6i) were
increased and MMP3 (Fig. 6h) was decreased in all re-
pair groups compared with normal.
ASC sheet treatment led to a reduction in the scar-
associated gene COL3A1 (Fig. 6d). Expression of MMP3
was further reduced in the +ASC sheet group compared
with the repair only group (Fig. 6h); however, this effect may
not have been specific to ASC sheet treatment, because a
similar change was detected in the +HA group without an
ASC sheet. As flexor tendons are subjected to compression
loads at a number of locations along their length, their
extracellular matrix is often enriched in cartilage-associated
matrix [23]. Therefore, we evaluated the expression of cartil-
age matrix genes COL2A1 and ACAN and the chondrogenic
gene SOX9. Tendon injury dramatically reduced the expres-
sion of these three genes in all repair groups. In contrast,
ASC sheet treatment led to recovery of COL2A1 expression
to levels similar to normal tendons (Fig. 6j). Similarly, the
reduction of ACAN expression in repaired tendons was
mitigated by ASC treatment (Fig. 6k). Likewise, SOX9
expression in the ASC sheet-repaired tendons was signifi-
cantly greater than that noted in the other two repair groups
(Fig. 6l). Taken together, results demonstrated the potential
of an ASC sheet to regulate tendon matrix formation and
remodeling during tendon healing.
Fig. 6 Change in expression of tendon-related genes in FDP tendons 7 days after repair. a SCX, b TNMD, c COL1A1, d COL3A1, e COL5A1, f DCN,
g MMP1, h MMP3, i MMP13, j COL2A1, k ACAN, l SOX9. *P < 0.05 between indicated groups. #P < 0.05 compared with normal tendons.
HA hyaluronan, ASC adipose-derived mesenchymal stromal cell
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Effect of ASC sheet treatment on tendon cell apoptosis
M1 macrophage activation has been linked to apoptotic
cell death [10, 15], and cell apoptosis at the flexor ten-
don repair site may contribute to adhesion formation
and affect the accrual of strength during healing [24, 25].
Therefore, we tested the ability of ASC sheet treatment,
presumably through promotion of the M2 macrophage
phenotype, to protect tendon cells from apoptotic cell
death following repair. Cleaved caspase 3 immunostain-
ing, which marks apoptotic cells [26], was performed on
tendon sections from the + HA and + ASC sheet groups
(N = 3 per group). Cleaved caspase 3 positive signal (in
red) primarily accumulated at the tendon surface (Fig. 7a,
b) and at the repair site (Fig. 7c, d). ASC treatment
(Fig. 7b, b′, d) reduced cleaved caspase 3 signals in both
regions.
Discussion
Repaired intrasynovial flexor tendons are susceptible to
gap formation and rupture during the first 3 weeks fol-
lowing suture, and to the formation of adhesions be-
tween the tendon and its surrounding synovial sheath
[1–5]. Although low levels of inflammatory cytokines are
likely necessary to attract FBs to the repair site [5, 6], a
marked inflammatory response after tendon suture has
been identified as a key factor leading to highly variable
clinical outcomes [6, 8, 15]. Control of the inflammatory
environment after operative repair is therefore a poten-
tial therapeutic target. In the current study, we demon-
strated that the delivery of ASCs to the surface of a
repaired tendon via a new ASC sheet approach was ef-
fective in modulating the inflammatory environment in
the early period after repair. Because recent evidence
suggests that fine modulation of inflammation in the
earliest stages following operative repair can improve
healing [12, 15, 16, 27], the approach presented here
holds great promise for enhancing flexor tendon repair.
The findings in the current study are consistent with a
prior in-vitro report demonstrating that ASCs suppress
the negative effects of macrophages on TFs by inducing
a phenotypic switch from the proinflammatory M1
macrophage phenotype to the anti-inflammatory M2
macrophage phenotype [15]. Prior in vitro and in vivo
studies in other tissues have also shown that MSCs have
the capacity to alter the inflammatory environment and
improve the healing response [16, 27–29]. However, it
remains unclear how ASCs regulate inflammation during
tendon healing. ASCs may secrete factors that modulate
macrophage activity by promoting changes in macro-
phage differentiation or cytokine expression patterns,
may secrete factors that modulate TF activity leading to
reduced sensitivity to cytokines such as IL-1B, and/or
may inactivate circulating proinflammatory factors (e.g.,
by releasing factors that degrade or sequester circulating
proinflammatory cytokines). The results of the current
study support the premise that the primary effect of
ASC application is modulation of macrophage differenti-
ation. The application of ASCs in vivo led to increased
expression of the M2 stimulator genes IL-4 and IL-13
and the M2 marker genes CD163 and MRC1. This con-
cept is supported further by the histological results, which
demonstrated that implanted ASCs accumulated at the
tendon surface and within the repair site, where infiltrat-
ing monocytes first arrived and CD163+ cells were initially
detected. The coappearance of ASCs and macrophages
indicates a likely interaction between the two cell types.
Previous reports have indicated that the interaction may
be mediated via a paracrine mechanism [30]. Nevertheless,
Fig. 7 Impact of ASC sheets on tendon cell apoptosis in FDP tendons 7 days after repair. Representative immunofluorescence images of FDP
tendon sections from the + HA (A, A′, and C) or + ASC sheet (B, B′, and D) groups at the tendon surface (A, A′, B, and B′) or repair site (C and D).
All sections were stained for cleaved caspase 3 (red) and DAPI nuclear stain (blue). E Location index indicating the location of A–D relative to
tendon repair in a tendon section with H&E staining. A–D Braces indicate epitenon regions. C, D Dotted lines indicate site of tendon transection.
Bar = 100 μm for A and B, bar = 50 μm for A′ and B′, and bar = 100 μm for C and D
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the underlining mechanisms are still unclear. Besides
macrophages, ASCs may have also influenced the function
of other neighboring cells by modulating the local mo-
lecular environment.
The functional significance of the M2 phenotype is its
potential to improve tendon healing by promoting
angiogenesis, cell proliferation, and matrix remodeling
while concurrently suppressing cell death and tissue
damage [11, 15, 28]. Consistently, the current study re-
vealed that ASC treatment promoted VEGF expression,
retained expression of tendon matrix genes COL2A1 and
COL3A1 levels closer to the levels found in the healthy
tissue, and suppressed tendon cell apoptosis. The ability
of ASCs to promote the M2 phenotype and modulate
the inflammatory environment may be influenced by
factors such as the magnitude and chronicity of the
injury, the age of patient, and the source of the cells.
However, it has been shown that the potency of ASCs
can also be modified by exogenous stimuli [31], thus
broadening the potential applications of ASCs to mul-
tiple tendon pathologies and patient populations. Lon-
ger time points of healing are necessary, however, to
determine whether these findings will result in func-
tional improvements.
Despite the apparent induction of M2 macrophages
by ASCs, there was no significant reduction in major
proinflammatory cytokine genes (e.g., IL-1B and
IFNG) in the current study. This discrepancy may
have resulted from a variation in individual responses
to injury and ASCs, as indicated by the relatively high
standard deviations seen in the gene expression
results. In addition, given the massive scale of initial
inflammatory responses after tendon repair [6], modu-
lation of the natural response may require a longer
interval. In prior studies, a suppressive effect of ASCs
on IL-1B expression was undetectable until 5 days
after ASC–macrophage coculture [15]. Because both
implanted ASCs and macrophages need to migrate to
the repair site, it may take even longer time to detect
this effect in vivo.
A major challenge in biological enhancement of intra-
synovial tendon healing is the necessity to stimulate
extracellular matrix formation at the repair site (to im-
prove tendon strength) while at the same time suppress-
ing extracellular matrix formation at the tendon surface
(to allow for gliding). Delivery of cells and/or growth
factors to repaired tendons can stimulate adhesions if
they are not localized to the repair site and effectively
isolated from the intrasynovial space [9]. The current
study explores a new solution to this problem. ASCs
were formed into sheets and wrapped around the tendon
at the repair site. To prevent stimulation of adhesions
and to anchor the ASC sheet to the tendon, a thin layer
of HA hydrogel was applied superficially to the ASC
sheet. The approach resulted in viable ASCs infiltrating
the tendon repair site by 7 days post operation. Of im-
portance, there were no adhesions noted in any of the
treated repairs. This is in contrast to a recent study
where ASCs and the growth factor BMP-12 were im-
planted in the interior of the tendon via surgically gener-
ated slits [8]. In that study, a low-grade inflammatory
reaction developed due to the polymer-based scaffold,
negating any positive effects from the treatment. Future
studies using the new cell sheet platform will incorpor-
ate growth factors along with stem cells and will test the
potential to improve both functional and structural
outcomes.
There were a number of limitations to the current
study. First, due to the study’s focus on demonstrating
the feasibility of a new approach and the emphasis on
the early inflammatory processes, only one early time
point was examined. Although the ASCs were shown to
influence the inflammatory response, it is not known
whether this modulation will result in longer-term func-
tional benefits. However, now that the novel method has
been established as safe and effective in the short term,
the efficacy of the approach can be explored further in
longer-term studies. Second, gene expression results do
not always correlate with protein expression levels and
activities. However, current immunohistochemical re-
sults strongly supported one of the primary gene expres-
sion outcomes of the study: the M2 phenotypic marker
CD163 was significantly increased in the ASC-treated
group compared with control. This result is strength-
ened by prior proteomics data from healing FDP ten-
dons, which confirmed the substantial accumulation of
CD163 proteins after ASC treatment [8]. Third, the
mechanisms by which ASCs promote the M2 phenotype
were not explored in the current study. Furthermore,
M1 and M2 phenotypes lie at the extremes of a con-
tinuum of macrophage expression profiles, and it re-
mains unclear whether certain M1 characteristics
remain after ASC treatment.
Conclusions
In summary, a cell sheet approach was used to deliver
autologous ASCs to the surface of repaired flexor
tendons in a clinically relevant large animal model. The
ASC sheets modulated the inflammatory phase of
tendon healing, as demonstrated by gene expression and
immunohistological assessment 7 days post repair. Spe-
cifically, ASCs promoted a regenerative/anti-inflamma-
tory M2 macrophage phenotype and influenced tendon
extracellular matrix remodeling, angiogenesis, and cell
survival. Future studies will explore the potential for this
approach to enhance functional outcomes after flexor
tendon repair.
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